Taken together, this suggests that MYB normally supports the leukaemia phenotype in MLL-rearranged AML by directly or indirectly limiting MAFB expression, with the additional possibility of suppression of MAFB protein activity, thereby limiting the ability of the cells to differentiate. This evidence concerns the gene KMT2A and acute myeloid leukemia.